Apparatus for acquiring biosignals in the presence of HF interference

Inventors

SALIGA, THOMAS V • Bibian, Stéphane • Zikov, Tatjana

Assignees

Neurowave Systems Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12207948-B1

Patent

Publication Date

2025-01-28

Expiration Date


Abstract

The present invention herein is a method and apparatus that significantly limits the effect of high frequency (“HF”) interferences on acquired electro-physiological signals, such as the EEG and EMG. Preferably, this method comprises of two separate electronic circuitries and steps or electronics for processing the signals. One circuit is used to block the transmission of HF interferences to the instrumentation amplifiers. It is comprised of a front-end active filter, a low frequency electromagnetic interference (“EMI”) shield, and an isolation barrier interface which isolates the patient from earth ground. The second circuit is used to measure the difference in potential between the two isolated sides of the isolation barrier. This so-called “cross-barrier” voltage is directly representative of the interference level that the instrumentation amplifier is subjected to. This circuit is used to confirm that the acquired signals are not corrupted by the interference.

Core Innovation

The invention relates to an apparatus for acquiring signals from a subject in the presence of high frequency (HF) interference. The apparatus includes at least 2 electrodes adapted for attaching to the subject, where each electrode acquires a signal when attached to the subject, and amplification circuitry for HF rejection connected to the at least 2 electrodes. The HF rejection circuitry comprises at least one active input filter for HF electrical interference rejection and an isolation barrier where power is transmitted via an optimized transformer.

The circuitry measures the quantitative level of HF interference across the isolation barrier and transmits both the acquired signals and the measured HF interference level to a processor. This enables the processor to receive a measurement of the HF interference level together with the biosignals for the acquisition process.

The described system architecture includes an isolation barrier configured with power transmitted via an optimized transformer and associated isolation barrier implementation elements. The invention further includes measurement of cross-barrier voltage and transmission of the measured HF interference level with the acquired signals to support confirmation of interference levels and subsequent signal handling behavior.

Claims Coverage

The document provides one independent apparatus claim. The inventive coverage is driven by two core requirements: HF rejection amplification circuitry with an active input filter and an isolation barrier with power transmitted via an optimized transformer, and measuring and transmitting a quantitative HF interference level across the isolation barrier to a processor alongside the acquired signals.

Quantitative HF interference measurement across an isolation barrier with signal transmission

The circuitry measures the quantitative level of HF interference across said isolation barrier, and transmits the acquired signals and measured HF interference level to a processor.

HF rejection amplification circuitry with active input filter

Amplification circuitry for HF rejection connected to said at least 2 electrodes, with said circuitry comprising at least one active input filter for HF electrical interference rejection.

Isolation barrier with power transmitted via an optimized transformer

An isolation barrier where power is transmitted via an optimized transformer.

Overall, the claims cover an apparatus that acquires subject signals via at least 2 electrodes while HF rejection circuitry includes an active input filter and an isolation barrier powered by an optimized transformer, and measures and transmits a quantitative HF interference level across the isolation barrier to a processor together with the acquired signals.

Stated Advantages

Provides a quantitative HF interference level measurement across the isolation barrier for the processor along with the acquired signals.

Documented Applications

Used in an anesthesia or sedation drug delivery system.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.